 Katharina Hopp
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polycystic Kidney, Autosomal Dominant | 26 | 2023 | 209 | 6.710 |
Why?
| | TRPP Cation Channels | 17 | 2022 | 63 | 3.490 |
Why?
| | Polycystic Kidney Diseases | 8 | 2023 | 55 | 2.360 |
Why?
| | Kidney | 15 | 2023 | 1210 | 1.930 |
Why?
| | Mutation | 14 | 2022 | 3371 | 1.260 |
Why?
| | Energy Metabolism | 3 | 2022 | 713 | 1.190 |
Why?
| | Tryptophan | 2 | 2023 | 136 | 0.850 |
Why?
| | Adaptive Immunity | 2 | 2020 | 157 | 0.740 |
Why?
| | Renal Agents | 1 | 2020 | 5 | 0.710 |
Why?
| | Caloric Restriction | 1 | 2020 | 89 | 0.650 |
Why?
| | Mice, Inbred C57BL | 13 | 2023 | 4780 | 0.600 |
Why?
| | Disease Models, Animal | 13 | 2023 | 3587 | 0.540 |
Why?
| | Mice | 21 | 2023 | 15087 | 0.530 |
Why?
| | Kidney Failure, Chronic | 2 | 2020 | 491 | 0.500 |
Why?
| | Hyperoxaluria, Primary | 1 | 2015 | 14 | 0.490 |
Why?
| | Mutation, Missense | 4 | 2015 | 297 | 0.490 |
Why?
| | Hepatocyte Nuclear Factor 1-beta | 1 | 2014 | 4 | 0.490 |
Why?
| | Arginine Vasopressin | 1 | 2014 | 46 | 0.490 |
Why?
| | DNA Mutational Analysis | 3 | 2014 | 378 | 0.490 |
Why?
| | Receptors, Vasopressin | 1 | 2014 | 18 | 0.490 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2021 | 688 | 0.480 |
Why?
| | Genetic Loci | 2 | 2013 | 280 | 0.480 |
Why?
| | Somatostatin | 1 | 2014 | 53 | 0.470 |
Why?
| | Metabolome | 3 | 2022 | 286 | 0.470 |
Why?
| | Benzazepines | 1 | 2014 | 37 | 0.470 |
Why?
| | Animals | 27 | 2023 | 32162 | 0.470 |
Why?
| | Heterozygote | 1 | 2015 | 254 | 0.470 |
Why?
| | Genetic Association Studies | 2 | 2016 | 352 | 0.460 |
Why?
| | Disease Progression | 5 | 2022 | 2423 | 0.390 |
Why?
| | Encephalocele | 1 | 2011 | 7 | 0.390 |
Why?
| | Ciliary Motility Disorders | 1 | 2011 | 21 | 0.380 |
Why?
| | Protein Folding | 1 | 2012 | 243 | 0.380 |
Why?
| | Decision Support Techniques | 1 | 2014 | 353 | 0.380 |
Why?
| | Kidney Diseases | 1 | 2014 | 355 | 0.370 |
Why?
| | Patient Selection | 1 | 2014 | 655 | 0.370 |
Why?
| | Sequence Deletion | 1 | 2011 | 167 | 0.370 |
Why?
| | Phenotype | 8 | 2022 | 2859 | 0.360 |
Why?
| | Exons | 1 | 2011 | 303 | 0.360 |
Why?
| | Cysts | 3 | 2022 | 94 | 0.340 |
Why?
| | Tumor Microenvironment | 3 | 2021 | 424 | 0.320 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2020 | 361 | 0.280 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2019 | 153 | 0.280 |
Why?
| | Mice, Transgenic | 3 | 2018 | 1971 | 0.280 |
Why?
| | Metabolomics | 2 | 2022 | 536 | 0.280 |
Why?
| | Alleles | 3 | 2018 | 818 | 0.270 |
Why?
| | Polycystic Kidney, Autosomal Recessive | 2 | 2019 | 6 | 0.260 |
Why?
| | Kynurenine | 2 | 2023 | 80 | 0.260 |
Why?
| | Pedigree | 7 | 2018 | 474 | 0.250 |
Why?
| | Proteins | 1 | 2011 | 920 | 0.250 |
Why?
| | Mice, Knockout | 5 | 2023 | 2609 | 0.240 |
Why?
| | Mice, Mutant Strains | 2 | 2022 | 271 | 0.230 |
Why?
| | Ureteral Obstruction | 2 | 2021 | 54 | 0.230 |
Why?
| | B7-1 Antigen | 1 | 2023 | 54 | 0.220 |
Why?
| | Fibrosis | 3 | 2021 | 458 | 0.220 |
Why?
| | Lung Neoplasms | 3 | 2021 | 2206 | 0.220 |
Why?
| | Tryptophan Oxygenase | 1 | 2023 | 22 | 0.220 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 44 | 0.210 |
Why?
| | Lipoxygenase Inhibitors | 2 | 2021 | 36 | 0.210 |
Why?
| | Humans | 25 | 2023 | 115879 | 0.210 |
Why?
| | Kidney Tubules | 3 | 2019 | 107 | 0.200 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 964 | 0.200 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2021 | 13 | 0.200 |
Why?
| | Arachidonate 15-Lipoxygenase | 1 | 2021 | 16 | 0.200 |
Why?
| | Nephritis | 1 | 2021 | 19 | 0.200 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 138 | 0.200 |
Why?
| | Female | 21 | 2022 | 60082 | 0.200 |
Why?
| | Male | 22 | 2022 | 56117 | 0.190 |
Why?
| | Databases, Genetic | 1 | 2022 | 211 | 0.180 |
Why?
| | Trehalose | 1 | 2020 | 29 | 0.180 |
Why?
| | Combined Modality Therapy | 1 | 2023 | 1127 | 0.180 |
Why?
| | Monocytes | 1 | 2023 | 504 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2019 | 377 | 0.180 |
Why?
| | Nutritive Value | 1 | 2020 | 30 | 0.180 |
Why?
| | Cilia | 3 | 2022 | 163 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 1 | 2022 | 414 | 0.170 |
Why?
| | Naphthyridines | 1 | 2019 | 16 | 0.170 |
Why?
| | Cardiomegaly | 1 | 2020 | 161 | 0.170 |
Why?
| | Mosaicism | 1 | 2019 | 63 | 0.170 |
Why?
| | Receptors, Cell Surface | 2 | 2019 | 358 | 0.170 |
Why?
| | Macrophages | 2 | 2023 | 1282 | 0.170 |
Why?
| | Cell Cycle Proteins | 2 | 2019 | 555 | 0.160 |
Why?
| | Chemokines | 1 | 2020 | 214 | 0.160 |
Why?
| | Orofaciodigital Syndromes | 1 | 2018 | 1 | 0.160 |
Why?
| | Protein Kinase C | 1 | 2020 | 274 | 0.160 |
Why?
| | Epithelial Cells | 3 | 2019 | 961 | 0.160 |
Why?
| | Ciliopathies | 1 | 2018 | 6 | 0.160 |
Why?
| | Inflammation Mediators | 1 | 2021 | 480 | 0.160 |
Why?
| | Cell Line | 3 | 2020 | 2657 | 0.160 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 352 | 0.160 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 21 | 0.160 |
Why?
| | Sirolimus | 1 | 2019 | 192 | 0.150 |
Why?
| | Trans-Activators | 1 | 2020 | 369 | 0.150 |
Why?
| | Energy Intake | 1 | 2020 | 413 | 0.150 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 176 | 0.140 |
Why?
| | Amino Acid Sequence | 4 | 2018 | 2003 | 0.140 |
Why?
| | alpha-Glucosidases | 1 | 2016 | 9 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 446 | 0.140 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 3 | 0.130 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2015 | 10 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 733 | 0.130 |
Why?
| | Biomarkers | 3 | 2021 | 3474 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2020 | 595 | 0.130 |
Why?
| | Adult | 8 | 2023 | 30822 | 0.130 |
Why?
| | Hypodermoclysis | 1 | 2014 | 4 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 2 | 2022 | 2201 | 0.120 |
Why?
| | Drinking | 1 | 2014 | 33 | 0.120 |
Why?
| | Rats | 4 | 2019 | 5035 | 0.120 |
Why?
| | Antidiuretic Agents | 1 | 2014 | 7 | 0.120 |
Why?
| | Antidiuretic Hormone Receptor Antagonists | 1 | 2014 | 8 | 0.120 |
Why?
| | Deamino Arginine Vasopressin | 1 | 2014 | 10 | 0.120 |
Why?
| | Immunotherapy | 1 | 2018 | 481 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2020 | 735 | 0.120 |
Why?
| | Food | 1 | 2015 | 160 | 0.120 |
Why?
| | Cytokines | 1 | 2021 | 1858 | 0.110 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 140 | 0.110 |
Why?
| | Molecular Chaperones | 1 | 2015 | 157 | 0.110 |
Why?
| | Multiprotein Complexes | 1 | 2015 | 145 | 0.110 |
Why?
| | Cyclic AMP | 1 | 2014 | 227 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 488 | 0.110 |
Why?
| | Liver Diseases | 1 | 2016 | 263 | 0.110 |
Why?
| | Signal Transduction | 4 | 2019 | 4528 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 789 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2015 | 235 | 0.110 |
Why?
| | Gene Knock-In Techniques | 1 | 2012 | 47 | 0.110 |
Why?
| | Base Sequence | 2 | 2018 | 2121 | 0.100 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 216 | 0.100 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 2750 | 0.100 |
Why?
| | Amino Acid Substitution | 1 | 2012 | 267 | 0.100 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2590 | 0.100 |
Why?
| | Models, Genetic | 1 | 2014 | 579 | 0.100 |
Why?
| | Gene Order | 1 | 2011 | 27 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 962 | 0.100 |
Why?
| | Time Factors | 1 | 2022 | 6182 | 0.100 |
Why?
| | Retinitis Pigmentosa | 1 | 2011 | 16 | 0.100 |
Why?
| | Intracellular Space | 1 | 2011 | 68 | 0.090 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2015 | 690 | 0.090 |
Why?
| | Cell Membrane | 1 | 2014 | 683 | 0.090 |
Why?
| | Cytoskeletal Proteins | 1 | 2011 | 145 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 328 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2021 | 9164 | 0.080 |
Why?
| | Protein Transport | 1 | 2011 | 400 | 0.080 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2796 | 0.080 |
Why?
| | Penetrance | 1 | 2009 | 27 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 10510 | 0.080 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 737 | 0.080 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 605 | 0.080 |
Why?
| | Child | 6 | 2022 | 18539 | 0.080 |
Why?
| | Gene Dosage | 1 | 2009 | 129 | 0.080 |
Why?
| | Autophagy | 2 | 2020 | 236 | 0.080 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 193 | 0.080 |
Why?
| | Infant | 3 | 2018 | 7992 | 0.070 |
Why?
| | Child, Preschool | 3 | 2018 | 9165 | 0.070 |
Why?
| | Fetus | 1 | 2011 | 703 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 839 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2015 | 3072 | 0.070 |
Why?
| | Adolescent | 4 | 2021 | 17940 | 0.070 |
Why?
| | Middle Aged | 5 | 2018 | 27085 | 0.060 |
Why?
| | Aged | 4 | 2018 | 19296 | 0.060 |
Why?
| | Phosphorylation | 2 | 2019 | 1562 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2004 | 0.060 |
Why?
| | Receptors, Chemokine | 1 | 2023 | 43 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2019 | 2196 | 0.050 |
Why?
| | Endocannabinoids | 1 | 2022 | 37 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2502 | 0.050 |
Why?
| | Genetic Background | 1 | 2021 | 8 | 0.050 |
Why?
| | Pravastatin | 1 | 2021 | 28 | 0.050 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 78 | 0.050 |
Why?
| | Autophagy-Related Protein 12 | 1 | 2020 | 3 | 0.050 |
Why?
| | Autophagy-Related Protein 5 | 1 | 2020 | 5 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2020 | 39 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2019 | 3914 | 0.050 |
Why?
| | Major Histocompatibility Complex | 1 | 2021 | 220 | 0.050 |
Why?
| | Apoptosis | 2 | 2019 | 2377 | 0.040 |
Why?
| | Leukocytes | 1 | 2021 | 284 | 0.040 |
Why?
| | rab GTP-Binding Proteins | 1 | 2020 | 63 | 0.040 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2019 | 18 | 0.040 |
Why?
| | Rats, Inbred Lew | 1 | 2019 | 93 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 26 | 0.040 |
Why?
| | Suppressor of Cytokine Signaling 1 Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2019 | 21 | 0.040 |
Why?
| | Chemokine CXCL9 | 1 | 2019 | 22 | 0.040 |
Why?
| | Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2019 | 45 | 0.040 |
Why?
| | Aborted Fetus | 1 | 2018 | 2 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 113 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 192 | 0.040 |
Why?
| | Loop of Henle | 1 | 2018 | 1 | 0.040 |
Why?
| | Gene Silencing | 1 | 2019 | 176 | 0.040 |
Why?
| | Uromodulin | 1 | 2018 | 21 | 0.040 |
Why?
| | Nephrons | 1 | 1998 | 16 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2019 | 116 | 0.040 |
Why?
| | Mixed Function Oxygenases | 1 | 1998 | 37 | 0.040 |
Why?
| | Ultrasonography | 2 | 2013 | 669 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 310 | 0.040 |
Why?
| | Genotype | 2 | 2016 | 1830 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1998 | 108 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 389 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2262 | 0.040 |
Why?
| | Isoenzymes | 1 | 1998 | 287 | 0.040 |
Why?
| | RNA Splicing | 1 | 2018 | 244 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 399 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2019 | 349 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2016 | 154 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2016 | 353 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2016 | 82 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2016 | 399 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 299 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2019 | 1644 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1871 | 0.030 |
Why?
| | Forecasting | 1 | 2016 | 333 | 0.030 |
Why?
| | Family | 1 | 2018 | 597 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3054 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1001 | 0.030 |
Why?
| | Heredity | 1 | 2013 | 12 | 0.030 |
Why?
| | False Positive Reactions | 1 | 2013 | 111 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1045 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1551 | 0.030 |
Why?
| | Europe | 1 | 2013 | 343 | 0.030 |
Why?
| | Genetic Linkage | 1 | 2013 | 314 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 2013 | 151 | 0.030 |
Why?
| | Canada | 1 | 2013 | 337 | 0.030 |
Why?
| | Haplotypes | 1 | 2013 | 475 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4447 | 0.020 |
Why?
| | Genetic Testing | 1 | 2013 | 383 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1814 | 0.020 |
Why?
| | Family Health | 1 | 2009 | 199 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6434 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2010 | 1359 | 0.020 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 1998 | 4 | 0.010 |
Why?
| | Kidney Cortex | 1 | 1998 | 23 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1998 | 34 | 0.010 |
Why?
| | Kidney Medulla | 1 | 1998 | 29 | 0.010 |
Why?
| | Arterioles | 1 | 1998 | 40 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 1998 | 102 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1998 | 324 | 0.010 |
Why?
| | Sex Characteristics | 1 | 1998 | 643 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1998 | 2581 | 0.010 |
Why?
| | Liver | 1 | 1998 | 1693 | 0.010 |
Why?
|
|
Hopp's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|